SMTL ID : 7p7a.1

SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-3-2-mer
Ligands
10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(5-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Walter, J.D. et al., Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance. Embo Rep. (2022)
Release Date
2021-08-04
Peptides
Spike glycoprotein: ABC
sybody#68: DE
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B
B
C
C
E
D
A
E
D